Cardinal Health, Inc. $CAH Shares Bought by Summit Global Investments

Summit Global Investments grew its position in Cardinal Health, Inc. (NYSE:CAH) by 27.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 61,714 shares of the company’s stock after acquiring an additional 13,191 shares during the period. Cardinal Health comprises 0.6% of Summit Global Investments’ portfolio, making the stock its 28th largest holding. Summit Global Investments’ holdings in Cardinal Health were worth $9,687,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CAH. SJS Investment Consulting Inc. boosted its holdings in Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC lifted its holdings in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares during the period. American Capital Advisory LLC boosted its stake in shares of Cardinal Health by 5,200.0% in the third quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after buying an additional 208 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC grew its holdings in Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 71 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have commented on CAH. Evercore ISI raised their target price on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Wells Fargo & Company raised their price objective on shares of Cardinal Health from $221.00 to $237.00 and gave the company an “overweight” rating in a research note on Thursday, January 15th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a report on Tuesday, November 18th. TD Cowen reaffirmed a “buy” rating on shares of Cardinal Health in a report on Tuesday. Finally, Jefferies Financial Group boosted their price target on Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, January 22nd. Fourteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $224.73.

Cardinal Health Trading Up 0.3%

Shares of CAH opened at $211.02 on Friday. Cardinal Health, Inc. has a 12-month low of $120.72 and a 12-month high of $216.51. The stock has a market cap of $50.14 billion, a P/E ratio of 31.83, a PEG ratio of 1.43 and a beta of 0.65. The company has a 50-day moving average of $206.13 and a two-hundred day moving average of $177.53.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The firm had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the previous year, the firm posted $1.88 EPS. The company’s quarterly revenue was up 22.4% compared to the same quarter last year. As a group, analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd were issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal hit an all-time high, reinforcing upside momentum and drawing more attention from momentum and trend-following buyers. Cardinal Health stock hits all-time high at $215.54
• Positive Sentiment: Morgan Stanley upgraded competitor Cencora, calling a “golden era” for drug distributors — a sector-level endorsement that likely lifts sentiment for Cardinal as a leading distributor. Cencora upgraded as Morgan Stanley cites a “golden era” for drug distributors
• Positive Sentiment: Multiple brokers and analysts are highlighting CAH as a top pick for Q4/early 2026, citing solid earnings trends and cooled inflation — this increases the likelihood of continued analyst revisions and inflows. 5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
• Positive Sentiment: Zacks expects CAH to report growing earnings next week and notes the company has the characteristics of a likely earnings beat — a near-term catalyst that can push the stock higher if results confirm expectations. Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release
• Positive Sentiment: High-profile bullish commentary (e.g., Jim Cramer saying he can see CAH reaching $300) can attract retail flows and increase trading momentum. Jim Cramer on Cardinal Health: “I Can See That Stock Going to $300”
• Positive Sentiment: IBD highlights raised 2026 guidance and strong momentum, reinforcing the narrative that growth and execution are improving — supports higher valuations. IBD Stock Of The Day: Why Cardinal Health’s Momentum Is ‘Special’ — And Not Over Yet
• Positive Sentiment: Short interest fell ~15.9% in January, lowering potential downside pressure from short-covering dynamics and removing a near-term bearish crowd — fewer shorts can mean steadier rallies. (data summary)
• Neutral Sentiment: Zacks published a valuation-focused piece asking whether CAH is undervalued — useful for longer-term investors but less of an immediate price catalyst. Is Cardinal Health (CAH) Stock Undervalued Right Now?
• Neutral Sentiment: Routine earnings calendar note: Cardinal is expected to announce quarterly results Thursday — the report itself is the key near-term event that could change the stock’s direction. Cardinal Health (CAH) Expected to Announce Quarterly Earnings on Thursday

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.